Aurora Cannabis Expands into Portugal, Enhancing European Market Leadership

February, 26, 2019 Aurora Cannabis Expands into Portugal, Enhancing European Market Leadership New Production Facility to Expand Supply to European Medical Cannabis Systems, Increasing Aurora’s International Footprint to 24 Countries   EDMONTON, Feb. 26, 2019 /CNW/ – Aurora Cannabis Inc. (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) today announced that it has agreed to terms to acquire

GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Quarter Ended December 31, 2018

February, 26, 2019 GW Pharmaceuticals plc Reports Financial Results and Operational Progress for the Quarter Ended December 31, 2018 LONDON and CARLSBAD, Calif., Feb. 26, 2019 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (NASDAQ: GWPH, GW, the Company or the Group), the world leader in the development and commercialization of cannabinoid prescription medicines, announces financial results

Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results: Gross Sales of $98M; Net Revenue hits record $83M

February, 14, 2019   Canopy Growth Corporation Reports Third Quarter Fiscal 2019 Financial Results: Gross Sales of $98M; Net Revenue hits record $83M • Cannabis shipments totaled 10,102 kilograms and kilogram equivalents. • Net income of $74.9 million, including changes in fair values of financial liabilities included in Other Income. • Closed the previously announced

Aurora Cannabis Announces Financial Results for the Second Quarter of Fiscal 2019

February, 11, 2019   EDMONTON, Feb. 11, 2019 /CNW/ – Aurora Cannabis Inc. (the “Company” or “Aurora“) (NYSE: ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM), announced today its financial and operational results for the second quarter ended December 31st, 2018. Q2 2019 and Subsequent Highlights Net revenue of $54.2 million, up 83% sequentially, and up 363% compared to the same